-
NYU Dataset
Lymphatic Vessels Limits the Intratumoral T cell Repertoire in Melanoma
- Authors
- Maria M. SteeleIan D. DrygDhaarini MuruganJulia Femel6 more author(s)...
- Description
CD8+ T cell accumulation in tumors is essential for effective immunotherapy. However, the mechanisms of lymphocyte transit are still unclear. This study examined lymphatic vessel-mediated effector CD8+ T cell exit limits the accumulation of a broad repertoire of functional CD8+ T cells that improve tumor control in combination with immune checkpoint blockade. They showed that tumor-associated lymphatic...
- Subject
-
CancerGenomics
- Access Rights
- Application RequiredAuthor Approval Required
-
NYU Dataset
Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in Non-Small Cell Lung Cancer
- Authors
- Kwan Ho TangShuai LiAlireza Khodadadi-JamayranJayu Jen14 more author(s)...
- Description
SHP2 plays critical roles in normal cell signaling and SHP2 inhibitors alone and in various combinations are being tested in multiple tumors with overactivation of the RAS/ERK pathway. This study showed that inhibiting the SHP2/RAS/ERK pathway triggers upregulation of CXCR2 ligands. In this study, C57BL/6J mice were used as the orthotopic allograft lung cancer model. They injected KP cells into the...
- Subject
-
CancerGenomics
- Access Rights
- Free to All
-
NYU Dataset
CXCR6 Promotes Dermal CD8+ T Cell Survival and Transition to Long-Term Tissue Residence
- Authors
- Taylor A. HeimZiyan LinMaria M. SteeleTenny Mudianto1 more author(s)...
- Description
Resident memory T cells (TRM) provide localized protection due to their position in barrier tissues. However, interstitial signals necessary for their formation and persistence are not properly understood. This study demonstrated that antigen-dependent induction of the chemokine receptor, CXCR6, is a conserved requirement for TRM formation in peripheral tissue after viral infection. They used cutaneous...
- Subject
-
Genomics
- Access Rights
- Application RequiredAuthor Approval Required
-
NYU Dataset
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection
- Authors
- Ellie IvanovaJasmine ShwetarJoseph C. DevlinTerkild B. Buus17 more author(s)...
- Description
To investigate immune responses to SARS-CoV-2 antigens under various inflammatory conditions, researchers collected blood samples from five adult patients seen at NYU Langone Health with lab-confirmed cases of acute COVID-19 and from nine healthy adults (seven who had received the BNT162b2 mRNA vaccine and two with no prior exposure to SARS-CoV-2). Samples were obtained at multiple time points. Patients...
- Subject
-
COVID-19GenomicsInfectious Disease
- Access Rights
- Free to All
-
NYU Dataset
Lymphatic Vessel Transit Seeds Precursors to Cytotoxic Resident Memory T Cells in Skin Draining Lymph Nodes
- Authors
- Taylor A. HeimAustin C. SchultzInes DelclauxVanessa Cristaldi2 more author(s)...
- Description
Resident memory T cells (TRM) provide localized protection in peripheral tissues to pathogens and cancer. However, how they develop during primary infection and their functional significance still remains unclear. This study observed the anatomical distribution of anti-viral CD8+ T cells as they simultaneously seed skin and lymph nodes (LN) TRM. They used a model of skin infection with restricted antigen...
- Subject
-
Genomics
- Access Rights
- Application RequiredAuthor Approval Required
-
NYU Dataset
Targeting of Intracellular Oncoproteins with Peptide-Centric Chimeric Antigen Receptors
- Authors
- Mark YarmarkovichQuinlen F. MarshallJohn M. WarringtonRasika Premaratne24 more author(s)...
- Description
This study demonstrated that the neuroblastoma immunopeptidome is enriched with peptides derived from proteins essential for tumorigenesis. They targeted the unmutated peptide QYNPIRTTF discovered on HLA-A*24:02, which is derived from the neuroblastoma-dependency gene and master transcriptional regulator PHOX2B. To target QYNPIRTTF, they developed peptide-centric chimeric antigen receptors (PC-CARs)...
- Subject
-
CancerProteomics
- Access Rights
- Free to All
-
NYU Dataset
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination
- Alternate Title(s)
- Vaccine‐generated Immunity in Ocrelizumab‐treated Patients: Longitudinal Assessments (VIOLA)
- Authors
- Ilya KisterRyan CurtinAmanda L. PiquetTyler Borko16 more author(s)...
- Description
This is a prospective, two-year study of immunity against SARS-CoV-2 in multiple sclerosis patients receiving ocrelizumab (OCR) at the time of COVID vaccination. Researchers recruited 60 patients (aged 18-65) from the NYU MS Comprehensive Care Center in New York City and the Rocky Mountain MS Center at the University of Colorado Anschutz Medical Center in Aurora, CO. Participants provided blood samples...
- Subject
-
Chronic DiseaseCOVID-19
- Access Rights
- Free to All